Home » Stocks » PGEN

Precigen, Inc. (PGEN)

Stock Price: $8.45 USD 0.26 (3.17%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
After-hours: $8.40 -0.05 (-0.59%) Mar 5, 6:54 PM
Market Cap 1.64B
Revenue (ttm) 103.18M
Net Income (ttm) -170.52M
Shares Out 167.07M
EPS (ttm) -1.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $8.45
Previous Close $8.19
Change ($) 0.26
Change (%) 3.17%
Day's Open 8.42
Day's Range 7.55 - 8.48
Day's Volume 1,228,313
52-Week Range 1.26 - 11.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 4 days ago

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 31.25% and -16.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the st...

PRNewsWire - 4 days ago

GERMANTOWN, Md., March 1, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the l...

Zacks Investment Research - 1 week ago

Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InvestorPlace - 2 weeks ago

The next GME will be hard to find, but these three stocks could be solid candidates for a potential short squeeze. The post 3 Troll-able Stocks That Could Be the Next GME appeared first on Inv...

Other stocks mentioned: CLVS, NAKD
PRNewsWire - 1 month ago

GERMANTOWN, Md., Feb. 4, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the li...

Benzinga - 1 month ago

The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causin...

Other stocks mentioned: CLVS, DVAX, LCI, NAKD, OPK, SENS, TXMD, UMC, VBIV
PRNewsWire - 1 month ago

GERMANTOWN, Md., Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously announced underwritten public offering of common stock. Precigen sold...

PRNewsWire - 1 month ago

GERMANTOWN, Md., Jan. 22, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public...

PRNewsWire - 1 month ago

GERMANTOWN, Md., Jan. 21, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced it has commenced an underwritten public offering of shares of its common stock. In addition, Precig...

PRNewsWire - 1 month ago

GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the l...

PRNewsWire - 1 month ago

GERMANTOWN, Md., Jan. 6, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the li...

PRNewsWire - 2 months ago

GERMANTOWN, Md., Jan. 5, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the li...

PRNewsWire - 2 months ago

GERMANTOWN, Md., Dec. 15, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the l...

PRNewsWire - 2 months ago

GERMANTOWN, Md., Dec. 7, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients...

Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Precigen, Inc. f/k/a Intrexon Corpora...

Other stocks mentioned: XON
Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - December 4, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precig...

Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - December 4, 2020) -  Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 3, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (...

Other stocks mentioned: XON
Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - December 3, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Preci...

PRNewsWire - 3 months ago

NEW YORK, Dec. 3, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Precigen, Inc. f/k/a Intrexon Corporation ("Precigen" or t...

Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - December 2, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now....

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - December 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Precigen, Inc. f/k/a Intrexon...

Other stocks mentioned: XON
Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - December 2, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precig...

PRNewsWire - 3 months ago

SAN FRANCISCO, Dec. 1, 2020 /PRNewswire/ -- Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securities fraud c...

Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - November 30, 2020) -  Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses no...

Business Wire - 3 months ago

LOS ANGELES--(BUSINESS WIRE)---- $PGEN #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 4, 2020 deadline to file a lead plaintiff motion in the class a...

Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - November 30, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Preci...

Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - November 29, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now...

GlobeNewsWire - 3 months ago

SAN FRANCISCO, Nov. 28, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Precigen, Inc. (N ASDAQ : PGEN ) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securities...

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Precigen, Inc. f/k/a (NASDAQ:...

Other stocks mentioned: XON
Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - November 27, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now...

Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - November 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Preci...

PRNewsWire - 3 months ago

NEW YORK, Nov. 27, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities c...

Other stocks mentioned: XON
Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)-- #Intrexon--Scott+Scott Attorneys at Law LLP Alerts Investors to December 4 Lead Plaintiff Deadline in Securities Class Actions Against Precigen, Inc. (PGEN)

Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - November 24, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - November 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation ...

Other stocks mentioned: XON
Newsfile Corp - 3 months ago

San Francisco, California--(Newsfile Corp. - November 17, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now...

PRNewsWire - 3 months ago

GERMANTOWN, Md., Nov. 16, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the l...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - November 13, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation ...

Other stocks mentioned: XON
Benzinga - 3 months ago

Shares of Precigen (NASDAQ:PGEN) were unchanged after the company reported Q3 results.

PRNewsWire - 3 months ago

GERMANTOWN, Md., Nov. 9, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the li...

Newsfile Corp - 4 months ago

San Francisco, California--(Newsfile Corp. - November 3, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now....

Insider Monkey - 4 months ago

Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees),...

Newsfile Corp - 4 months ago

San Francisco, California--(Newsfile Corp. - October 29, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now....

Business Wire - 4 months ago

LOS ANGELES--(BUSINESS WIRE)---- $PGEN #CLASSACTION--PGEN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - October 28, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation ...

Other stocks mentioned: XON
PRNewsWire - 4 months ago

NEW YORK, Oct. 26, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Precigen, Inc. f/k/a Intrexon Corporation ("Precigen" or ...

PRNewsWire - 4 months ago

BENSALEM, Pa., Oct. 26, 2020 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming December 4, 2020 deadline to file a lead plaintiff motion in the class action file...

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - October 22, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (...

Other stocks mentioned: XON
PRNewsWire - 4 months ago

LOS ANGELES, Oct. 21, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming December 4, 2020 deadline to file a lead plaintiff motion in the class action f...

Other stocks mentioned: XON

About PGEN

Precigen discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic component... [Read more...]

Industry
Biotechnology
Founded
1998
CEO
Helen Sabzevari
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
PGEN
Full Company Profile

Financial Performance

In 2020, Precigen's revenue was $103.18 million, an increase of 13.73% compared to the previous year's $90.72 million. Losses were -$170.52 million, -47.10% less than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Precigen stock is "Buy." The 12-month stock price forecast is 11.83, which is an increase of 40.00% from the latest price.

Price Target
$11.83
(40.00% upside)
Analyst Consensus: Buy